China's TCM product developer Tasly Pharmaceutical Group Co., Ltd. issued a white paper on digital intelligence of traditional Chinese medicine (TCM) and launched a related large model at an industrial conference on May 9, 2024.

May14,2024

A group of Chinese experts Monday shared experience in fighting against the COVID-19 outbreak with experts from the United States and Europe at the International Symposium on COVID-19 Treatment (Webcast).

April08,2020

Tasly Holding Group, one of China's leading pharmaceuticals companies, has recently passed through the country's review of National Technology Innovation Demonstration Enterprise in 2019, thanks to its continuous innovations made in the recent years.

August15,2019

Traditional Chinese medicine has big potential to become part of mainstream health service in the United States especially in the areas where Western medicine reaches its limitation, said several TCM experts. 

November29,2018

Tasly Pharmaceutical Group Co., Ltd. (referred to as “Tasly”) and the US-based drug maker Arbor Pharmaceuticals, Inc. (referred to as “Arbor”) announced on Sep. 6 comprehensive cooperation in the R&D and marketing of T89 in the States. 

September09,2018

Tasly Pharmaceutical Group CO.,LTD (600535.SH) announced that it had inked investment agreement and product development commercialization agreement with Mesoblast, the world's leading stem cell R&D company.

July18,2018

A center of Traditional Chinese medicine (TCM) opened Friday in Hanover, Germany, aiming to promote the integrative use of TCM and modern medicine. 

June08,2018

 An online regulation platform for traditional Chinese medicine (TCM) has opened in Anguo city, Hebei Province, the biggest TCM market in north China. 

May24,2017